Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clinical Trials Lung CancerNew York

Lung Cancer Clinical Trials in New York

Find 246 clinical trials for lung cancer near New York, New York. Connect with research centers in your area.

All Lung Cancer trials nationwide All trials in New York

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 221-240 of 246 trials

TerminatedErlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung CancerThis randomized phase II trial studies how well erlotinib hydrochloride or crizotinib with chemoradiation therapy works in treating patients with stage III non-small cell lung…NCT01822496·Birmingham, Alabama and 173 others

Lung Cancer Trials in Other Cities

Los Angeles Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

WithdrawnNEUWAVE Flexible Probe Study #2Patients with medically inoperable and operable secondary soft tissue lesion(s) of the lung will have transbronchial microwave ablation performed using cone beam CT for probe…NCT03713099·Duarte, California and 4 others

RecruitingA Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)Researchers are looking for new ways to treat locally advanced non-small cell lung cancer (NSCLC) that is unresected and has a gene mutation called KRAS G12C.NCT07554339·Lisle, Illinois and 90 others

Active not recruitingAnvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).The study aims to determine maximum tolerated dose (MTD) or recommended combination dose of the MTA-cooperative PRMT5 inhibitor Anvumetostat administered in combination with other…NCT06333951·Bakersfield, California and 82 others

Active not recruitingA Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)The reason for this study is to see if the study drug, selpercatinib, compared to placebo is effective and safe in delaying cancer return in participants with early-stage…NCT04819100·Los Angeles, California and 210 others

Active not recruitingGenetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery.NCT02194738·Birmingham, Alabama and 1659 others

CompletedPemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerThis randomized phase II trial studies pemetrexed disodium and sunitinib malate to compare how well they work when given alone or together as second-line therapy in treating…NCT00698815·Anaheim, California and 128 others

CompletedStudy of Talabostat and Docetaxel in Advanced Non-Small Cell Lung CancerThe purpose of this study is to determine the antitumor activity (response rate, time to tumor progression, survival) and safety of docetaxel in combination with talabostat in…NCT00080080·Ocoee, Florida and 9 others

Active not recruitingTesting the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung CancerThis phase III trial studies whether pembrolizumab alone as a first-line treatment, followed by pemetrexed and carboplatin with or without pembrolizumab after disease progression…NCT03793179·Mobile, Alabama and 1093 others

CompletedA Study of DKN-01 in Multiple Myeloma or Advanced Solid TumorsThe purpose of this trial is to characterize the safety and toxicity of DKN-01 by determining a maximum-tolerated dose and associated dose limiting toxicity.NCT01457417·Scottsdale, Arizona and 7 others

CompletedRadiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung DysfunctionRATIONALE: Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.NCT00009789·Fort Lauderdale, Florida and 19 others

CompletedPROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCLThe purpose of this first-in-human study of CX-2029 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-2029 in…NCT03543813·Birmingham, Alabama and 24 others

Active not recruitingA Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid TumorsThis is an open-label, dose-exploration and expansion study to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of…NCT05585320·Scottsdale, Arizona and 19 others

CompletedManuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung CancerRATIONALE: Manuka honey may prevent or reduce esophagitis-related pain caused by chemotherapy and radiation therapy.NCT01262560·Mobile, Alabama and 58 others

CompletedPrognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by SurgeryRATIONALE: Prognostic testing for early signs of metastases may help doctors detect metastases early and plan more effective treatment.NCT00003901·Mobile, Alabama and 57 others

CompletedA Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet ChemotherapyThis Phase III, global, multicenter, open-label, randomized, controlled study will evaluate the efficacy and safety of atezolizumab (an anti-programmed death-ligand 1…NCT03191786·Buenos Aires and 90 others

CompletedS9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00004011·Birmingham, Alabama and 286 others

RecruitingA Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)Researchers want to learn if the study medicines calderasib and subcutaneous (SC) pembrolizumab can be used to treat non-small cell lung cancer (NSCLC) when given together.NCT07190248·Birmingham, Alabama and 217 others

CompletedStudy of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung CancerThis Phase 1/2 clinical trial is a multi-center, open-label study with three main objectives.NCT00066885·Berkeley, California and 10 others

CompletedA Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing TherapyThis global, multicenter, open-label, randomized, controlled study evaluated the efficacy and safety of atezolizumab (an anti-programmed death-ligand 1 \[anti-PD-L1\]…NCT02008227·Bakersfield, California and 207 others

PreviousPage 12 of 13Next

Other Conditions in New York

Breast Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma

Clareo Health | Lung Cancer Clinical Trials in New York | 246 Studies